GMRE
Global Medical REIT Inc.
NYSE: GMRE · REAL ESTATE · REIT - HEALTHCARE FACILITIES
$35.98
-0.03% today
Updated 2026-02-20
Market cap
$979.78M
P/E ratio
—
P/S ratio
6.77x
EPS (TTM)
$-0.26
Dividend yield
10.00%
52W range
$26 – $38
Volume
0.1M
WallStSmart proprietary scores
52
out of 100
Grade: C
Hold
Investment rating
4.0
Growth
C3.5
Quality
D3.5
Profitability
D5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
-0.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$40.86
+13.56%
12-Month target
—
—
Intrinsic (DCF)
$48.68
Margin of safety
+24.51%
2 Strong Buy3 Buy4 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ 24.51% below intrinsic value
Risks
- Altman Z -0.31 — distress zone
- Thin margins at 0.02%
- Negative free cash flow $-88.00M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $137.17M | $140.93M | $138.41M | $148.21M | $144.83M |
| Net income | $19.14M | $20.61M | $6.63M | $-12.12M | $-11.78M |
| EPS | — | — | — | — | $-0.26 |
| Free cash flow | $-79.66M | $58.39M | $-25.07M | $-8.08M | $-88.00M |
| Profit margin | 13.96% | 14.63% | 4.79% | -8.17% | 0.02% |
Peer comparison
Smart narrative
Global Medical REIT Inc. trades at $35.98. Our Smart Value Score of 52/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -0.31, it sits in the distress. TTM revenue stands at $144.83M. with profit margins at 0.02%. Our DCF model estimates intrinsic value at $48.68.
Frequently asked questions
What is Global Medical REIT Inc.'s stock price?
Global Medical REIT Inc. (GMRE) trades at $35.98, on a P/S of 6.8x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Global Medical REIT Inc. overvalued?
Global Medical REIT Inc. carries a Smart Value Score of 52/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $48.68 versus the $35.98 price, a 24.5% margin of safety on a cash flow basis.
What is the price target of Global Medical REIT Inc. (GMRE)?
The 12-month analyst consensus target is $40.86, about 13.6% above the current $35.98. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Global Medical REIT Inc. (GMRE)?
Our DCF model estimates intrinsic value at $48.68, a +24.5% margin of safety versus today's $35.98. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Global Medical REIT Inc.'s revenue?
Global Medical REIT Inc.'s trailing twelve-month revenue is $144.83M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Global Medical REIT Inc.'s Altman Z-Score is -0.31, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorREAL ESTATE
IndustryREIT - HEALTHCARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio6.77x
ROE-2.50%
Beta1.20
50D MA$35.24
200D MA$34.14
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week+0.00%
1 month+0.00%
3 months+0.00%
YTD+6.64%
1 year—
3 years—
5 years—